Hoku Health Care Llc | |
6167b Heron Ave Ewa Beach HI 96706-3341 | |
(808) 210-4454 | |
Not Available |
Full Name | Hoku Health Care Llc |
---|---|
Speciality | Family Medicine |
Location | 6167b Heron Ave, Ewa Beach, Hawaii |
Authorized Official Name and Position | Emese Torok (OWNER) |
Authorized Official Contact | 8082104454 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Hoku Health Care Llc 6167b Heron Ave Ewa Beach HI 96706-3341 Ph: (808) 210-4454 | Hoku Health Care Llc 6167b Heron Ave Ewa Beach HI 96706-3341 Ph: (808) 210-4454 |
NPI Number | 1457101859 |
---|---|
Provider Enumeration Date | 03/26/2024 |
Last Update Date | 03/26/2024 |
Identifier | Type | State | Issuer |
---|---|---|---|
1457101859 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | (* (Not Available)) | Primary |
363LF0000X | Nurse Practitioner - Family | (* (Not Available)) | Secondary |
News Archive
Mylan Laboratories Inc. has announced that the U.S. Court of Appeals for the Federal Circuit upheld a district court decision that Mylan's Oxybutynin products do not infringe a patent for DITROPAN XL and that the patent was invalid.
Is the world prepared a wave of neurological consequences that may be on its way as a result of COVID-19? This question is at the forefront of research underway at the Florey Institute of Neuroscience and Mental Health.
Researchers pinpoint a small RNA that spurs cells to manufacture a particular splice variant of a key neuronal protein, potentially promoting Alzheimer's disease or other types of neurodegeneration.
Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the publication in Science of research describing novel molecules designed to treat or prevent infection by the virus that causes COVID-19, SARS-CoV-2.
Tolerx, Inc., today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety and efficacy of otelixizumab, a targeted T cell immunomodulator, in patients with new-onset autoimmune type 1 diabetes.
› Verified 3 days ago
James M Warner Md Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 91-2141 Fort Weaver Rd, Ewa Beach, HI 96706 Phone: 808-678-7370 Fax: 808-678-7240 | |
Drt Medical Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 91-2141 Fort Weaver Rd, Ewa Beach, HI 96706 Phone: 808-678-7000 | |
Empower Health Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 91-6390 Kapolei Pkwy, Ewa Beach, HI 96706 Phone: 808-691-4600 | |
Access Medical Clinics Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 91-1401 Fort Weaver Rd, Ewa Beach, HI 96706 Phone: 808-285-2448 | |
West Oahu Acupuncture And Integrative Medicine Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 91-1123 Keaunui Dr Ste 223, Ewa Beach, HI 96706 Phone: 808-638-4559 Fax: 781-998-2412 | |
Waianae District Comprehensive Health And Hospital Board, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 91-1841 Fort Weaver Rd, Ewa Beach, HI 96706 Phone: 808-697-3300 | |
Rachel Tortolini Md,llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 91-896 Makule Rd Ste 102, Ewa Beach, HI 96706 Phone: 808-689-4414 Fax: 808-689-7115 |